Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: A randomized controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 478-485

  Fantin, Simone De Souza ^a   Wainstein, Marco Vugman ^a   Polanczyk, Carísi Anne ^a   Ledur, Priscila ^a   Lazzari, Carmen Maria ^a   Klein, Cristini ^a,b   Hackenhaar, Fernanda Schäfer ^a,b   Benfato, Mara Silveira ^a,b   Schaan, Beatriz D'Agord ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CD40 LIGAND; CLOPIDOGREL; ENDOTHELIN 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LIPID; TICLOPIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STENT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 79951705073     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0256     Document Type: Article

References (37)

1. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schömig A 1998 Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32:1866-1873 (Pubitemid 29010448)
2. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D 2002 Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072 (Pubitemid 35192812)
3. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW 2004 Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43:8-14 (Pubitemid 38045906)
4. D'Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A, Gandjbakhch I, Bonnet N 2007 Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 134:29-37 (Pubitemid 46970705)
5. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N 2009 Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373:1765-1772
6. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G 2003 Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088 (Pubitemid 36337759)
7. Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, Nagai R, Komuro I 2000 Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102:2873-2879
8. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE 2004 Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27:461-467 (Pubitemid 38174072)
9. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
10. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ 2009 Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94:709-728
11. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
12. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER 1990 Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478 (Pubitemid 20279989)
13. Smith Jr SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith Jr SC 2001 ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 103:3019-3041 (Pubitemid 32586088)
14. Martens FM, Visseren FL, de Koning EJ, Rabelink TJ 2005 Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes. J Cardiovasc Pharmacol 46:773-778 (Pubitemid 44378249)
15. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982 (Pubitemid 36121050)
16. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A 2003 Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021 (Pubitemid 36644877)
17. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A 2005 Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26:650-661 (Pubitemid 40516876)
18. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE 2009 American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119-1131
19. Alhadad A, Guron G, Fortuna-Nowakowska E, Saeed A, Mattiasson I, Jensen G, Lindblad B, Gottsäter A, Herlitz H 2007 Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention. J Hypertens 25:1907-1914 (Pubitemid 47356632)
20. Li JJ, Fang CH, Jiang H, Hunag CX, Tang QZ, Wang XH, Li GS 2004 Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis. Angiology 55: 479-484 (Pubitemid 39237914)
21. Wainstein MV, Gonçalves SC, Zago AJ, Zenker R, Burttet R, Couto Gde B, Tomazi F, Ribeiro JP 2003 Plasma endothelin-1 levels after coronary stenting in humans. Am J Cardiol 92:1211-1214 (Pubitemid 37377837)
22. Cipollone F, Chiarelli F, Davi G, Ferri C, Desideri G, Fazia M, Iezzi A, Santilli F, Pini B, Cuccurullo C, Tumini S, Del Ponte A, Santucci A, Cuccurullo F, Mezzetti A 2005 Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48:1216-1224
23. Kersten JR, Toller WG, Tessmer JP, Pagel PS, Warltier DC 2001 Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281:H2097-H2104
24. Marfella R, Nappo F, De Angelis L, Paolisso G, Tagliamonte MR, Giugliano D 2000 Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 23:658-663 (Pubitemid 30321547)
25. Morohoshi M, Fujisawa K, Uchimura I, Numano F 1996 Glucosedependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954-959 (Pubitemid 26225513)
26. Hattori Y, Hattori S, Sato N, Kasai K 2000 High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells. Cardiovasc Res 46:188-197 (Pubitemid 30155959)
27. Furtado MV, Rossini AP, Campani RB, Meotti C, Segatto M, Vietta G, Polanczyk CA 2009 Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up. Coron Artery Dis 20:327-331
28. Dandona P, Aljada A, Mohanty P 2002 The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924-930
29. Koskenkari JK, Kaukoranta PK, Rimpiläinen J, Vainionpää V, Ohtonen PP, Surcel HM, Juvonen T, Ala-Kokko TI 2006 Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 50: 962-969 (Pubitemid 44272719)
30. Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA, van Wezel HB 2005 Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 95:448-457 (Pubitemid 41418737)
31. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P 2004 Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109:849-854 (Pubitemid 38252736)
32. Guha M, Bai W, Nadler JL, Natarajan R 2000 Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275:17728-17739 (Pubitemid 30430822)
33. Booth G, Stalker TJ, Lefer AM, Scalia R 2001 Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 280:E848-E856
34. Aljada A, Dandona P 2000 Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49:147-150 (Pubitemid 30090874)
35. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P 2000 Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 85:2572-2575 (Pubitemid 32269217)
36. Singh P, Jain A, Kaur G 2004 Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 260:153-159 (Pubitemid 39127583)
37. Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, Gozashti MH, Omidfar K, Taheri E 2009 Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 58:443-448